论文部分内容阅读
为超早期静脉应用“活血化瘀”药物治疗高血压性脑出血提供理论依据 ,脑出血在按部位分类的基础上 ,结合高血压性深穿支动脉系统的病理变化 ,将 1 58例高血压性脑出血进一步分为 :①单纯性脑出血。②反复性脑出血。③双重性卒中。其中②、③型分别占总数的 2 .5%和 1 4.6% ,说明二者在临床上并非少见。这三种类型脑出血因有共同的高血压小动脉坏死病理基础 ,均可采用大剂量复方丹参超早期静脉治疗。
To provide a theoretical basis for the treatment of hypertensive intracerebral hemorrhage by the application of “activating blood and removing blood stasis” in ultra-early venous blood circulation. Based on the site classification of cerebral hemorrhage and the pathological changes of hypertensive penetrating peroneal artery, 158 cases of hypertension Intracranial hemorrhage is further divided into: ① simple cerebral hemorrhage. ② recurrent cerebral hemorrhage. ③ double stroke. Which ②, ③ accounted for 2.5% and 14.6% of the total, indicating that the two are not uncommon clinical. These three types of cerebral hemorrhage due to common pathological basis of arteriolar necrosis can be treated with high-dose compound Salvia Ultra Early veins.